Cranberry Powder Attenuates Benign Prostatic Hyperplasia in Rats

다국어 초록 (Multilingual Abstract)

Cranberry powder (CR) is reported to be effective against lower urinary tract symptoms (LUTS) and recurrent urinary tract infections. Benign prostatic hyperplasia (BPH) in men older than 50 years is a common cause of LUTS. Here, we attempted to evaluate if CR is also effective for treating BPH using a BPH-induced rat model, which was orally administered CR. Male Sprague-Dawley rats weighing 200–250 g were randomly divided into the following six groups (n = 9): noncastration group; castration group; BPH group; BPH and cranberry for 8-week (CR8W) group; BPH and cranberry for 4-week (CR4W) group; and BPH and saw palmetto group (saw palmetto). Compared with the BPH group, the CR8W group showed a significant decrease in prostate weight (by 33%), dihydrotestosterone (DHT) levels (by 18% in serum and 28% in prostate), 5-alpha reductase levels (18% reduction of type 1 and 35% of type 2), and histological changes. These results indicate that CR could attenuate BPH by inhibiting 5-alpha reductase and by reducing other biomarkers such as prostate weight and DHT levels. Thus, CR may be an effective candidate for the development of a functional food for BPH treatment. IACUC (USW-IACUC-R-2015-004).

참고문헌 (Reference)

1 오상현, "전립선비대증 환자에서 Finasteride가 성기능에 미치는 영향" 대한비뇨의학회 43 (43): 611-618, 2002

2 Allkanjari O, "What do we know about phytotherapy of benign prostatic hyperplasia?" 126 : 42-56, 2015

3 Jean-Francois Bisson, "Therapeutic Effect of ACTICOA Powder, a Cocoa Polyphenolic Extract, on Experimentally Induced Prostate Hyperplasia in Wistar-Unilever Rats" 한국식품영양과학회 10 (10): 628-635, 2007

4 Kim EH, "The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia" 5 : 28-32, 2018

5 Carson C, "The role of dihydrotestosterone in benign prostatic hyperplasia" 61 : 2-7, 2003

6 Vidlar A, "The effectiveness of dried cranberries(Vaccinium macrocarpon)in men with lower urinary tract symptoms" 104 : 1181-1189, 2010

7 Hirata N, "Testosterone 5alpha-reductase inhibitory active constituents of Piper nigrum leaf" 30 : 2402-2405, 2007

8 Lu T, "Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia(BPH)development" 26 : 1707-1715, 2012

9 Ledda A, "Supplementation with high titer cranberry extract(Anthocran)for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia : A pilot study" 20 : 5205-5209, 2016

10 Schmidt LJ, "Steroid 5 a-reductase inhibitors targeting BPH and prostate cancer" 125 : 32-38, 2011

11 Bent S, "Saw palmetto for benign prostatic hyperplasia" 354 : 557-566, 2006

12 Gu X, "SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5a-reductase inhibitors and a-adrenergic receptor antagonists" 190 : 615-619, 2013

13 Roehrborn CG, "Pathology of benign prostatic hyperplasia" 20 : S11-S18, 2008

14 Elhilali MM, "Minimally invasive therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia" 177 : 820-821, 2007

15 Wong SY, "Lower urinary tract symptoms and depressive symptoms in elderly men" 96 : 83-88, 2006

16 de Grey ADNJ, "Life span extension research and public debate : Societal considerations" 1 : 1941-6008, 2007

17 Choi YJ, "In vivo effects of polymerized anthocyanin from grape skin on benign prostatic hyperplasia" 11 : 2444-, 2019

18 Abrams P, "In support of pressure-flow studies for evaluating men with lower urinary symptoms" 44 : 153-155, 1994

19 노유훈, "Improvement of andropause symptoms by dandelion and rooibos extract complex CRS-10 in aging male" 한국영양학회 6 (6): 505-512, 2012

20 Speakman MJ, "Guideline for the primary care management of male lower urinary tract symptoms" 93 : 985-990, 2004

21 Jing Chen, "Fraction of Macroporous Resin from Smilax china L. Inhibits Testosterone Propionate–Induced Prostatic Hyperplasia in Castrated Rats" 한국식품영양과학회 15 (15): 646-650, 2012

22 Bonetta A, "Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma" 4 : 281-286, 2012

23 Vattem DA, "Enhancing health benefits of berries through phenolic antioxidant enrichment : Focus on cranberry" 14 : 120-130, 2005

24 Guzma´n R, "Efficacy and tolerability of Roystonea regia lipid extract(D-004)and terazosin in men with symptomatic benign prostatic hyperplasia : A 6-month study" 11 : 1-2, 2019

25 Barry MJ, "Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms : A randomized trial" 306 : 1344-1351, 2011

26 Park HS, "Effect of Veratrum maackii on testosterone propionate-induced benign prostatic hyperplasia in rats" 42 : 1-9, 2019

27 Das K, "Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer" 17 : 757-770, 2010

28 Iehle´ C, "Differences in steroid 5alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue" 68 : 189-195, 1999

29 Ledda A, "Cranberry supplementation in the prevention of non-severe lower urinary tract infections : a pilot study" 19 : 77-80, 2015

30 McKay DL, "Cranberries(Vaccinium macrocarpon)and cardiovascular disease risk factors" 65 : 490-502, 2007

31 Blumberg JB, "Cranberries and their bioactive constituents in human health" 4 : 618-632, 2013

32 Jin BR, "Chinese Skullcap(Scutellaria baicalensis Georgi)inhibits inflammation and proliferation on benign prostatic hyperplasia in rats" 235 : 481-488, 2019

33 Makridakis NM, "Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II" 10 : 407-413, 2000

34 Youn DH, "Berberine improves benign prostatic hyperplasia via suppression of 5 alpha reductase and extracellular signal-regulated kinase in vivo and in vitro" 9 : 773-, 2018

35 Fenner A, "BPH : Go with the Flowens( )—Cranberry powder improves male LUTS in double-blind, placebo-controlled trial" 12 : 364-, 2015

36 Nardi GM, "Anti-inflammatory activity of berry fruits in mice model of inflammation is based on oxidative stress modulation" 8 : S42-S49, 2016

37 Kim KK, "Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells" 40 : 227-235, 2011

38 Li YF, "Anthocyanins extract from bilberry enhances the therapeutic effect of pollen of Brassica napus L. on stress-provoked benign prostatic hyperplasia in restrained mice" 5 : 1357-1365, 2013

39 Jang H, "Anthocyanin extracted from black soybean reduces prostate weight and promotes apoptosis in the prostatic hyperplasia-induced rat model" 58 : 12686-12691, 2010

40 Nicholson TM, "Androgens and estrogens in benign prostatic hyperplasia : Past, present and future" 82 : 184-199, 2011

41 Peng CC, "Action mechanism of ginkgo biloba leaf extract intervened by exercise therapy in treatment of benign prostate hyperplasia" 2013 : 408734-, 2013

42 Steers WD, "5a-reductase activity in the prostate" 58 : 17-24, 2001